title: Advances in clinical study of curcumin.
abstract: Curcumin has been estimated as a potential agent for many diseases and attracted great attention owing to its various pharmacological activities, including anti-cancer, and anti-inflammatory. Now curcumin is being applied to a number of patients with breast cancer, rheumatoid arthritis, Alzheimer's disease, colorectal cancer, psoriatic, etc. Several clinical trials have stated that curcumin is safe enough and effective. The objective of this article was to summarize the clinical studies of curcumin, and give a reference for future studies.
authors.affiliation: Department of Pharmaceutics, College of Pharmacy, Shandong University, Jinan 250012, China.
authors.forename: Chunfen
authors.initials: C
authors.lastname: Yang
authors.forename: Xun
authors.initials: X
authors.lastname: Su
authors.forename: Anchang
authors.initials: A
authors.lastname: Liu
authors.forename: Lin
authors.initials: L
authors.lastname: Zhang
authors.forename: Aihua
authors.initials: A
authors.lastname: Yu
authors.forename: Yanwei
authors.initials: Y
authors.lastname: Xi
authors.forename: Guangxi
authors.initials: G
authors.lastname: Zhai
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003474:Curcumin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000737:chemistry / Q000627:therapeutic use*; D005704:Gallbladder / Q000187:drug effects; D006801:Humans; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000972:Antineoplastic Agents, Phytogenic; D002317:Cardiovascular Agents; D003474:Curcumin